Abstract
Selective serotonin reuptake inhibitors (SSRIs) are widely used for treating depressive and anxiety disorders. Although SSRIs have a safety profile, some authors have reported that they associated with an increased risk of bleeding events. We report a case of paroxetine- and sertraline-associated ecchymoses in a patient with depression.
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Case Report
EUR J GEN MED, Volume 12, Issue 4, October 2015, 356-357
https://doi.org/10.15197/ejgm.01268
Publication date: 15 Oct 2015
Article Views: 1461
Article Downloads: 1323
Open Access References How to cite this article